GlassScriptPhysician profile
Hannah Salter
NPI 1972077915
$943.23
in general payments reported to CMS, 2019-2025
17 companies · $180 in 2025
The $180 reported for 2025 was more than what a typical Pediatrics (Nurse Practitioner) provider received nationally (typical 2025 total: $93.49).
See the full distribution for Pediatrics (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $118 · 2022: $70.15 · 2023: $295 · 2024: $280 · 2025: $180.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $661 · Long Term Medical Supply Or Device Loan: $93.31.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $661.49 |
| Long Term Medical Supply Or Device Loan | $93.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tris Pharma INC | $130.66 | 2021-2023 | Dyanavel Xr |
| Sobi, INC | $93.52 | 2021-2023 | |
| Sanofi-Aventis U.S. LLC | $93.34 | 2024-2025 | |
| Baxter Healthcare | $93.31 | 2024 | Hillrom - Spot Vision Screener |
| Corium, LLC | $87.12 | 2023-2025 | Azstarys |
| Cranial Technologies, INC | $61.88 | 2023-2025 | Doc Band |
| Collegium Pharmaceutical, INC. | $60.42 | 2025 | Jornay Pm |
| Astrazeneca Pharmaceuticals LP | $54.88 | 2023-2024 | Flumist Quadrivalent |
| Ironshore Pharmaceuticals INC. | $54.85 | 2023-2024 | Jornay Pm |
| Genentech USA, INC. | $44.27 | 2024 | Xolair |
| Takeda Pharmaceuticals U.S.A., INC. | $43.22 | 2021-2023 | |
| Kaleo, INC. | $38.06 | 2021-2023 | Auvi-Q |
| Exeltis, USA INC. | $21.39 | 2025 | Slynd |
| Seqirus USA INC | $20.67 | 2023 | Flucelvax Quadrivalent |
| Tempus Ai, INC | $17.49 | 2024 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $14.17 | 2023 | Vaxelis, Gardasil 9, M-M-R II |
| Phadia US INC. | $13.98 | 2025 | Immunocap |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hannah Salter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.